NovaSight
NovaSight

News

June 27, 2023

NoCamels

Children Watch TV To Cure Their ‘Lazy Eye’
Read More
May 11, 2023

NoCamels

Israeli Innovators Fix Their Gaze On Eye Health
Read More
March 30, 2023

Eye World

Insights on amblyopia therapies
Read More
February 8, 2023

The Ophthalmologist

Amblyopia Treatment: Upgraded
How red-blue treatment glasses, algorithms, and eye-tracking technology combine to gain better results while boosting adherence
Read More
December 23, 2022

Healio

Video: CureSight platform shows promise in pediatric amblyopia treatment
Read More
December 16, 2022

Vision Monday

NovaSight Introduces CureSight to U.S. Market and Names Drew Hopper as VP of Sales and Marketing
Read More
December 16, 2022

Ophthalmology Breaking News

NovaSight Announces Commercial Release of CureSight in the US
Read More
December 16, 2022

Ophthalmology Times

NovaSight introducing CureSight to U.S. market
Read More
December 15, 2022

Healio

Digital amblyopia therapy released to US market
Read More
December 15, 2022

Eye Wire News

NovaSight Announces Commercial Release of CureSight in the US; Names a New VP of Sales & Marketing
Read More
December 15, 2022

INVISION

NovaSight Introduces CureSight to US, and Names VP of Sales and Marketing
Read More
November 16, 2022

Healio

At-home digital amblyopia treatment found noninferior to patching
Read More
November 16, 2022

Optometry Advisor

Home-Based Amblyopia Treatment Improves Vision, Treatment Adherence in Children
Read More
October 28, 2022

Healio

VIDEO: NovaSight CEO discusses CureSight vs. patching for amblyopia treatment
Read More
October 24, 2022

Healio

NovaSight announces FDA clearance of CureSight digital therapy for amblyopia
Read More
October 12, 2022

Ophthalmology Times

FDA grants clearance for amblyopia treatment device
Read More
October 12, 2022

Review of Optometric Business

Digital Therapy Treatment for Amblyopia Receives FDA Clearance
Read More
October 10, 2022

Glance

Is there another way to treat amblyopia besides patching?
Read More
October 7, 2022

Fierce Biotech

NovaSight spots FDA nod for digital treatment for lazy eye in children
Read More
October 6, 2022

Vision Monday

NovaSight Announces FDA 510(K) Clearance of CureSight Digital Therapy for Amblyopia
Read More
October 5, 2022

Ophthalmology Breaking News

NovaSight Receives FDA Clearance of CureSight Digital Therapy for Amblyopia
Read More
October 5, 2022

EyeWire TV

FDA Clearance of NovaSight’s CureSight for Amblyopia
Read More
October 4, 2022

Eye Wire News

NovaSight Announces FDA 510(K) Clearance of CureSight Digital Therapy for Amblyopia
Read More
September 13, 2022

Geektime

Israel: A beacon of light helping with sight
Read More
September 12, 2022

Ynet

OPTIVISION – Optometry innovation conference hosted by Opticana
Read More
August 10, 2022

Review of Opthalmology

New Ways to Address Amblyopia
Read More
July 11, 2022

Reshet 13

Channel 13’s morning show where our CEO, Ran Yam talked about our technology
Read More
May 16, 2022

CRSToday

Make Patients Feel Seen
Read More
May 15, 2022

HealthDay News

ARVO 2022: Novel Binocular Treatment Safe, Effective for Amblyopia in Children
Read More
May 2, 2022

Healio

At-home treatment device may improve visual acuity in children with amblyopia
Read More
April 22, 2022

FutureIoT

Digital treatment for lazy eye on clinical trial in Shanghai
Read More
April 13, 2022

HKTDC Hong Kong Means Business

Lazy eye comes into focus
Read More
April 6, 2022

Healio

VIDEO: Digital treatment non-inferior to patching for amblyopia in study
Read More
March 16, 2022

EyeWire TV

NovaSight Announces Positive Data for Eye-Tracking Digital Device for Amblyopia
Read More
March 12, 2022

Ophthalmology Times

NovaSight releases successful results of amblyopia treatment trial
Read More
March 11, 2022

Ophthalmology 360

Digital treatment device non-inferior to eye patch for amblyopia treatment
Read More
March 11, 2022

Ophthalmology Breaking News

NovaSight Announces Successful Results of Pivotal Amblyopia Treatment Trial
Read More
March 11, 2022

Healio

Digital amblyopia treatment device non-inferior to eye patching in study
Read More
March 11, 2022

Medical Device Network

NovaSight reports positive data from amblyopia treatment device
Read More
March 10, 2022

Medical Device News Magazine

NovaSight Announces Positive Pivotal Results of Pivotal Amblyopia Treatment Trial
Read More
March 10, 2022

Eye Wire News

NovaSight Announces Successful Results of Pivotal Amblyopia Treatment Trial
Read More
February 1, 2022

Cookie Magazine by Media Mice

Cyberpunk Meets Eye Care
Read More
July 9, 2021

Vision Monday

NovaSight Is Assigned Three Unique CPT Codes by AMA for CureSight Amblyopia Treatment
Read More
July 3, 2021

Healio

CureSight platform offers amblyopia therapy
Read More
June 15, 2021

Review of Myopia Management

NovaSight Uses Eye-Tracking Technology to Develop Myopia Management Lens
Read More
June 6, 2021

Eyewire News

NovaSight Announces Establishment of Three Unique CPT Codes for the CureSight Digital Treatment for Lazy Eye
Read More
April 30, 2021

Review of Myopia Management

OIS Hosts Virtual Myopia Innovation Showcase
Read More
April 29, 2021

Review of Optometric Business

Telemedicine: Technologies for Optometry
Read More
March 16, 2021

Massdevice

NovaSight announces pivotal trial for digital lazy eye treatment
Read More
March 16, 2021

mobihealthnews

NovaSight eyes FDA clearance with upcoming clinical trial
Read More
March 1, 2021

StartUs Insights

NovaSight in the 5 Top Pediatrics Startups Impacting the Healthcare Sector
Read More
July 14, 2020

mobihealthnews

NovaSight raises $8 million in Series A financing to tackle vision disorders worldwide
Read More
July 14, 2020

GeekTime

NovaSight raises $8M for its AI-powered eye tracking solutions for visual disorders
Read More
July 13, 2020

Globes

Israeli AI eye tracking company NovaSight raises $8m
Read More
June 18, 2020

EyeNet Magazine – American Academy of Ophthalmology

Automated Test for Strabismus Proves Accurate
Read More
May 6, 2020

Review of Optometric Business

Telemedicine: The Time for Optometry is Now
Read More
January 22, 2020

CES

NovaSight’s CEO, Ran Yam, introduces the CureSight system at CES 2020.

Read More
January 21, 2020

CTECH by Calcalist

This Startup Cures Lazy Eye With Netflix and Disney
Read More
January 20, 2020

El Español

Eyeviz 300 was selected as the “Best Technology Initiative” at the III El Español Digital Awards
Read More
January 14, 2020

TechCrunch

Kids with lazy eye can be treated just by letting them watch TV on this special screen
Read More
January 13, 2020

Channel 12 news

Israeli companies present their innovative technologies at the CES exhibition in Las Vegas
Read More
January 8, 2020

Israel21c

20 Israeli companies to get excited about at CES 2020
Read More
January 7, 2020

Optometry TV

NovaSight: Eye Tracking-Based Pediatric Vision Care Solutions
Read More
January 7, 2020

Digital Trends

Ingenious system cures lazy eye as your kid watches shows on Netflix
Read More
November 25, 2019

Interview to Optometry TV

Moshe Barel, VP Sales & Marketing is interviewed by Optometry TV, during the AOA meeting.
Read More
September 19, 2019

Silmo d’Or

Essilor’s EyeViz 300 was nominated as one of three top products at the prestigious Silmo d’Or 2019 competition
Read More
August 28, 2019

SFO – French Ophthalmology Society meeting

Essilor launched NovaSight’s Vision assessment system at the French Ophthalmology Society (SFO) Meeting, in Paris
Read More
May 30, 2019

Channel 13 News

Innovative Israeli technology for lazy eye treatment
Read More
January 14, 2019

100% Optical

NovaSight’s CEO, Ran Yam introduces the EyeSwift® system, at the 100% optical meeting, London
Read More
August 13, 2018

Globes

Diagnosing vision problems from eye movement
Read More
May 22, 2017

Israel21c

10 breakthrough health techs emerging from Israel
Read More
Contact us
Find a Physician
NovaSight
Linkedin-in Youtube

Branding & Website by

Branding & Website by

© 2022 NovaSight | All Rights Reserved | NS-00779-R08
CureSight™ and EyeSwift®PRO devices are CE marked in accordance with EU Medical Device Regulation 2017/745.

CureSight™ is an FDA 510(K) cleared device.

Caution: The EyeSwift®PRO system is an Investigational Device, Limited By Federal (Or United States) Law To Investigational Use.
Currently, TrackSightTM is not approved for sales in any country.

Contact Us Today!
So children worldwide can pursue their dreams
(*Required field)

Your data will be handled in accordance with our Privacy Policy. In the event that a child’s or minor’s information is being submitted as part of this form, we hereby request that such information be submitted solely by the legal guardian of such child or minor.

This website uses cookies for functional, operational, analytical and advertising purposes. Please review our Privacy Policy for more information

Ok
Privacy Policy